Bringing the fundamentals into focus…
Back to Vanda Pharmaceuticals Inc.
How Vanda Pharmaceuticals Inc. stacks up
VNDA · against 266 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #171 of 267 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score97 peers with a valuation score of 0–9, including VNDA · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -121.2% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -222.6% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -63.1% vs peer median 0.0%
Metric by metric
Position: dot = VNDA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VNDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 250 reported | -123.7% | -0.6% | 2% | 30% | |
| EBITDA yieldHigher is better · 274 reported | -222.6% | 1.6% | 5% | 50% | |
| Free cash flow yieldHigher is better · 143 reported | -67.5% | -11.2% | 4% | 20% | |
| Book yieldHigher is better · 254 reported | 124.5% | 61.1% | 83% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around VNDA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 171 | 172M USD | 8 | 34 | |
| 171 | 371M USD | 8 | ||
| 171 | 394M USD | 8 | 37 | |
| 171 | 289M USD | 8 | ||
| 171 | 227M USD | 8 | 24 | |
| 171 | 453M USD | 8 | 6 | |
| 171 | 382M USD | 8 | ||
| 237 | 1.9B CNY (≈$270M) | 7 | 17 | |
| 237 | 3.2B CNY (≈$449M) | 7 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score